The American Society of Clinical Oncology warns against using ivermectin and fenbendazole for cancer outside trials due to lack of strong evidence. Dr. Paul Marik argues that current evidence standards ignore real-world data and are unfair to cheap, repurposed drugs. He suggests tracking patient outcomes as a better way to study these treatments and expand cancer care options.
ORIGINAL LINK: https://imahealth.substack.com/p/ivermectin-is-on-trial-again-this?utm_campaign=posts-open-in-app&triedRedirect=true







